KLRK1 and neoplasm: Certain levels of tumor cell killing were observed in the absence of TCR agonists (Figure 2F,I), indicating the intrinsic NK activating receptor (e.g., NKG2D, NKp30, and NKp44)-mediated tumor cell killing of innate T cells [4,8,28,33,34].